BlackRock Institutional Trust’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

BlackRock Institutional Trust’s Portfolio NAVB Stock Details NAVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.7M	Buy	132,975 +6,283	+5%	+$99.7K	﹤0.01%	3118
2016 Q3	$2.32M	Buy	126,692 +73,039	+136%	+$924K	﹤0.01%	2992
2016 Q2	$569K	Sell	53,653 -62,800	-54%	-$1.23M	﹤0.01%	3470
2016 Q1	$2.2M	Sell	116,453 -1,655	-1%	-$31.8K	﹤0.01%	3002
2015 Q4	$3.14M	Buy	118,108 +9,602	+9%	+$333K	﹤0.01%	2923
2015 Q3	$4.95M	Buy	108,506 +35,758	+49%	+$1.35M	﹤0.01%	2729
2015 Q2	$2.34M	Sell	72,748 -5,334	-7%	-$155K	﹤0.01%	3055
2015 Q1	$2.48M	Sell	78,082 -742	-0.9%	-$25.1K	﹤0.01%	3015
2014 Q4	$2.98M	Sell	78,824 -13,073	-14%	-$360K	﹤0.01%	2943
2014 Q3	$2.43M	Buy	91,897 +760	+0.8%	+$20.1K	﹤0.01%	2992
2014 Q2	$2.7M	Buy	91,137 +10,343	+13%	+$334K	﹤0.01%	3054
2014 Q1	$2.99M	Sell	80,794 -218	-0.3%	-$8.27K	﹤0.01%	2989
2013 Q4	$3.35M	Sell	81,012 -6,207	-7%	-$243K	﹤0.01%	2952
2013 Q3	$4.62M	Sell	87,219 -21,459	-20%	-$1.25M	﹤0.01%	2772
2013 Q2	$5.8M	Buy	+108,678	New	+$5.43M	﹤0.01%	2617

Other funds holding NAVB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

SFS

Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BlackRock Institutional Trust's NAVB Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Navidea Biopharmaceuticals Inc. (NAVB) stake by 5% in Q4 2016, buying an estimated $99.7K and bringing the position to 132,975 shares worth $1.7M. The position accounts for ﹤0.01% of the portfolio, ranked #3118.

BlackRock Institutional Trust first reported a position in NAVB in Q2 2013 and has held it in 15 quarters since. The position peaked at $5.8M in Q2 2013. 55 funds tracked by Wall St. Rank hold NAVB as of Q4 2016.

BlackRock Institutional Trust held 132,975 shares of Navidea Biopharmaceuticals Inc. worth $1.7M as of Q4 2016.
BlackRock Institutional Trust bought 6,283 Navidea Biopharmaceuticals Inc. shares in Q4 2016, an estimated $99.7K.
Navidea Biopharmaceuticals Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3118 holding.
BlackRock Institutional Trust first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Navidea Biopharmaceuticals Inc. position peaked at $5.8M in Q2 2013.
55 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.